基本信息
views: 5
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Dan Hertz joined the Department of Clinical Pharmacy in the College of Pharmacy in April 2013. He received his PharmD from the Ernest Mario School of Pharmacy at Rutgers University and his PhD in pharmaceutical sciences from the University of North Carolina Eshelman School of Pharmacy.
Interested in developing tools for individualizing cancer treatment, his current work focuses on the optimal use of paclitaxel in breast cancer. The approaches being developed include identifying an ideal exposure target to maximize efficacy while avoiding unnecessary toxicity, particularly as it relates to neuropathy. Hertz is also interested in understanding the influence of patient genetics on cancer treatment outcomes. He uses several approaches to discover and validate the effect of common variants on drug exposure or patient sensitivity to toxicity. Much of this work is conducted through his membership in oncology cooperative groups, which provide access to sufficiently large patient cohorts for definitive analyses.
Interested in developing tools for individualizing cancer treatment, his current work focuses on the optimal use of paclitaxel in breast cancer. The approaches being developed include identifying an ideal exposure target to maximize efficacy while avoiding unnecessary toxicity, particularly as it relates to neuropathy. Hertz is also interested in understanding the influence of patient genetics on cancer treatment outcomes. He uses several approaches to discover and validate the effect of common variants on drug exposure or patient sensitivity to toxicity. Much of this work is conducted through his membership in oncology cooperative groups, which provide access to sufficiently large patient cohorts for definitive analyses.
Research Interests
Papers共 181 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
The Pharmacogenomics Journalno. 2 (2024): 1-8
Tabea Tracksdorf,D Max Smith, Skyler Pearse, Emily J Cicali, Christina L Aquilante,Stuart A Scott, Teresa T Ho,Jai N Patel, J Kevin Hicks,Daniel L Hertz
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancerno. 8 (2024): 497-497
Pharmacogenetics and genomicsno. 4 (2024): 126-129
European Journal of Cancer (2024): 114024-114024
Ilia Rattsev,Vered Stearns, Amanda L Blackford,Daniel L Hertz, Karen L Smith,James M Rae,Casey Overby Taylor
JAMIA Openno. 1 (2024): ooae006-ooae006
Daniel L Hertz,Chad A Bousman,Howard L McLeod,Andrew A Monte,Deepak Voora,Lori A Orlando, Rustin D Crutchley,Benjamin Brown, Wrenda Teeple,Sara Rogers,Jai N Patel
Cancer Chemotherapy and Pharmacologypp.1-11, (2024)
Tabea Tracksdorf,D. Max Smith, Skyler Pearse,Emily J Cicali,Christina L Aquilante,Stuart A. Scott, Teresa T Ho,Jai N Patel, J. Kevin Hicks,Daniel L Hertz
crossref(2024)
Cancer Chemotherapy and Pharmacologyno. 6 (2024): 1-15
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn